Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$419,697
+$146,310 QoQ
Shares Held
1,159
+49.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,307
of 3,140 holders
Holding Since
Dec 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fortis Capital Advisors, LLC holds $12,414,388 across 8 Drug Manufacturers - General names. AMGN ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,684 | $4,418,700 | |
| 2 | ABBV |
AbbVie Inc.
|
16,124 | $4,057,443 | |
| 3 | JNJ |
Johnson & Johnson
|
4,470 | $1,135,245 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
13,795 | $794,867 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,018 | $644,813 | |
| 6 | PFE |
Pfizer Inc
|
21,511 | $517,984 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,369 | $425,639 | |
| 8 | AMGN |
Amgen Inc
This page
|
1,159 | $419,697 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,697 | 1,159 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $273,387 | 777 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $262,502 | 802 | Shares | Sole | 2026-01-27 | |
| 2024-09-30 | $207,825 | 645 | Shares | Sole | 2024-11-13 | |
| 2022-12-31 | $62,770 | 239 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||